NIH will take a multi-pronged approach to increase the number of NIH-funded early-stage and mid-career investigators and stabilize the career trajectory of scientists by:
- Further extending the payline for early stage investigators, with an aim of funding most applications that score in the top 25 percent
- Providing additional support for mid-career investigators with ≤ 10 years as a principal investigator
- Extending the payline for those about to lose all NIH funding
- Identifying “rising stars” who are seeking support for their second RPG, but just missed the payline
- NIH Common Fund’s New Innovator Awards
- National Institute of General Medicine Sciences Maximizing Investigators’ Research Award (MIRA)
- National Institute of Dental and Craniofacial Research Sustaining Outstanding Achievement in Research (SOAR) awards
- National Institute of Arthritis and Musculoskeletal and Skin Diseases Supplements to Advance Research (STAR) from Projects to Programs
- Other special awards from specific institutes